(Total Views: 106)
Posted On: 06/12/2023 8:25:59 AM
Post# of 85477

$FBIO News Article - Mustang Bio Announces Updated Results from Waldenstrom Macroglobulinemia Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR T Therapy https://marketwirenews.com/news-releases/must...00943.html


My Twitter: WhyteStocks